Background There are no clear expert consensus or guidelines on how to treat 2019
coronavirus disease (COVID-19). The objective of this study is to investigate the short-term …

Background The novel coronavirus disease 2019 (COVID-19) broke out globally. Early
prediction of the clinical progression was essential but still unclear. We aimed to evaluate …

Background: To investigate the risk factors related to aggravation and clinical outcomes in
coronavirus disease 2019 (COVID-19) patients. Methods: We performed a retrospective …

Background Since early December 2019, the 2019 novel coronavirus disease (COVID-19)
has caused pneumonia epidemic in Wuhan, Hubei province of China. This study aimed to …

Background The course of disease in mild and moderate COVID-19 has many implications
for mobile patients, such as the risk of spread of the infection, precautions taken, and …

In December 2019, a novel coronavirus causing severe acute respiratory disease occurred
in Wuhan, China. It is an emerging infectious disease with widespread and rapid …

Background A few studies have revealed the clinical characteristics of hospitalized patients
with COVID-19. However, predictive factors for the outcomes remain unclear. Objective …

Abstract Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) has become a worldwide pandemic since it …

Abstract Background Coronavirus disease (COVID-19) is rapidly spreading worldwide.
Although 10–20% of patients with COVID-19 have severe symptoms, little is known about …

Background 2019 novel coronavirus disease (COVID-19) has posed significant threats to
public health. To identify and treat the severe and critical patients with COVID-19 is the key …